- Home
- CLDX vs IART Comparison
CLDX vs IART Comparison
Compare CLDX & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- IART
- Stock Information
- Founded
- CLDX N/A
- IART 1989
- Country
- CLDX United States
- IART United States
- Employees
- CLDX N/A
- IART N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- IART Medical/Dental Instruments
- Sector
- CLDX Health Care
- IART Health Care
- Exchange
- CLDX Nasdaq
- IART Nasdaq
- Market Cap
- CLDX 1.6B
- IART 1.2B
- IPO Year
- CLDX 2008
- IART 1995
- Fundamental
- Price
- CLDX $24.50
- IART $15.07
- Analyst Decision
- CLDX Strong Buy
- IART Hold
- Analyst Count
- CLDX 9
- IART 8
- Target Price
- CLDX $46.13
- IART $18.17
- AVG Volume (30 Days)
- CLDX 1.6M
- IART 1.3M
- Earning Date
- CLDX 11-05-2025
- IART 11-03-2025
- Dividend Yield
- CLDX N/A
- IART N/A
- EPS Growth
- CLDX N/A
- IART N/A
- EPS
- CLDX N/A
- IART N/A
- Revenue
- CLDX $5,790,000.00
- IART $1,621,738,000.00
- Revenue This Year
- CLDX N/A
- IART $5.74
- Revenue Next Year
- CLDX N/A
- IART $4.35
- P/E Ratio
- CLDX N/A
- IART N/A
- Revenue Growth
- CLDX N/A
- IART 3.53
- 52 Week Low
- CLDX $14.40
- IART $11.06
- 52 Week High
- CLDX $47.00
- IART $27.13
- Technical
- Relative Strength Index (RSI)
- CLDX 57.57
- IART 55.43
- Support Level
- CLDX $22.44
- IART $14.92
- Resistance Level
- CLDX $25.51
- IART $15.73
- Average True Range (ATR)
- CLDX 1.22
- IART 0.61
- MACD
- CLDX 0.20
- IART -0.08
- Stochastic Oscillator
- CLDX 75.78
- IART 43.72
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.